Primary Site >> Stomach Cancer
Gene >> ARID1A
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Oxides, onions, and other matters gastrointestinal--1996--a perspective. PMID: 9179730 |
Ref: [Iodine-125 labeled monoclonal antibody 3H11: in radioimmunoguided surgery for primary gastric cancer]. PMID: 11832094 |
Ref: Subpleural injection of tracer improves detection of mediastinal sentinel lymph nodes in non-small cell lung cancer. PMID: 17766135 |
Ref: Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. PMID: 21412130 Ref: Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. PMID: 22037554 |
Ref: Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. PMID: 22009941 Ref: Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. PMID: 22484628 Ref: Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. PMID: 22808142 Ref: ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein-Barr virus infection and microsatellite instability. PMID: 22915242 Ref: Gastric cancer: basic aspects. PMID: 22958152 |
Ref: An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. PMID: 23208944 Ref: [Tumor suppressor role of chromatin-remodeling factor ARID1A]. PMID: 23575531 Ref: Gastric cancer-molecular and clinical dimensions. PMID: 24061039 Ref: The genomic landscape of oesophagogastric junctional adenocarcinoma. PMID: 24308032 |
Ref: ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas. PMID: 23887303 Ref: Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription. PMID: 24293408 Ref: An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa. PMID: 24744582 Ref: ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts. PMID: 24767857 Ref: Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection. PMID: 24786892 Ref: Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. PMID: 24816253 Ref: The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers. PMID: 25042771 |
Ref: Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing. PMID: 25427437 Ref: Frequent involvement of chromatin remodeler alterations in gastric field cancerization. PMID: 25462860 Ref: Loss of AT-rich interactive domain 1A expression in gastrointestinal malignancies. PMID: 25503393 Ref: Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. PMID: 25583476 Ref: Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma. PMID: 25613731 Ref: Update on Epstein-Barr virus and gastric cancer (review). PMID: 25633561 Ref: Microsatellite instability: an update. PMID: 25701956 Ref: Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies. PMID: 25882375 Ref: Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma. PMID: 26073375 Ref: Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer. PMID: 26334097 Ref: Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations. PMID: 26337667 Ref: Gene mutations in gastric cancer: a review of recent next-generation sequencing studies. PMID: 26364057 Ref: DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells. PMID: 26400522 Ref: Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features. PMID: 26468418 Ref: Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer. PMID: 26637902 |
Ref: Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency. PMID: 26067140 Ref: Various ARID1A expression patterns and their clinical significance in gastric cancers. PMID: 26826411 Ref: Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. PMID: 27221363 Ref: Comprehensive mutation profiling of mucinous gastric carcinoma. PMID: 27313181 Ref: Chromatin remodeling gene AT-rich interactive domain-containing protein 1A suppresses gastric cancer cell proliferation by targeting PIK3CA and PDK1. PMID: 27323812 Ref: Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies. PMID: 27354232 |
Ref: Epstein-Barr Virus-associated Gastric Cancer and Potential Mechanisms of Oncogenesis. PMID: 27677953 Ref: [Expression and clinical significance of ARID1A in gastric cancer and paired adjacent noncancerous tissues]. PMID: 28031120 Ref: DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy. PMID: 28233295 Ref: Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers. PMID: 28522256 Ref: Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing. PMID: 28744403 Ref: AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells. PMID: 28860825 Ref: Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysis. PMID: 28937020 |
Ref: Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. PMID: 29290541 Ref: NF-kappaB/miR-223-3p/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression. PMID: 29317648 Ref: Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features. PMID: 29438172 Ref: Four distinct immune microenvironment subtypes in gastric adenocarcinoma with special reference to microsatellite instability. PMID: 29636988 Ref: Loss of ARID1A expression is associated with poor prognosis in patients with gastric cancer. PMID: 29689245 Ref: Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer. PMID: 29725898 Ref: Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency. PMID: 29767248 Ref: Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer. PMID: 29896679 Ref: The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression. PMID: 30221053 Ref: Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk. PMID: 30249557 |